LRRC32 anticorps (AA 301-500) (HRP)
-
- Antigène Voir toutes LRRC32 Anticorps
- LRRC32 (Leucine Rich Repeat Containing 32 (LRRC32))
-
Épitope
- AA 301-500
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LRRC32 est conjugé à/à la HRP
-
Application
- ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Transforming growth factor beta activator LRRC32 protein (301-500AA)
- Isotype
- IgG
- Top Product
- Discover our top product LRRC32 Anticorps primaire
-
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 162-405) antibody
LRRC32 Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 234-260) antibodyLRRC32 Reactivité: Humain, Souris WB, IHC (p) Hôte: Lapin Polyclonal RB18218 unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 234-260) antibodyLRRC32 Reactivité: Humain, Souris WB, IHC, ELISA Hôte: Lapin Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 400-643) antibodyLRRC32 Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) antibodyLRRC32 Reactivité: Humain WB Hôte: Souris Monoclonal GARP5 unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 250-300) antibodyLRRC32 Reactivité: Humain, Souris, Rat, Singe WB, FACS Hôte: Lapin Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 301-500) antibodyLRRC32 Reactivité: Humain IHC, ELISA Hôte: Lapin Polyclonal unconjugated
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 20-627) antibody (FITC)LRRC32 Reactivité: Humain, Souris FACS Hôte: Souris Monoclonal Plato-1 FITC
anti-Leucine Rich Repeat Containing 32 (LRRC32) (AA 20-627) antibody (PE)LRRC32 Reactivité: Humain, Souris FACS Hôte: Souris Monoclonal Plato-1 PE
anti-Leucine Rich Repeat Containing 32 (LRRC32) antibody (Alexa Fluor 647)LRRC32 Reactivité: Souris FACS Hôte: Rat Monoclonal F011-5 Alexa Fluor 647
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- LRRC32 (Leucine Rich Repeat Containing 32 (LRRC32))
- Autre désignation
- LRRC32 (LRRC32 Produits)
- Sujet
-
Background: Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space (PubMed:19750484, PubMed:19651619, PubMed:22278742). Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta (PubMed:22278742). Able to outcompete LTBP1 for binding to LAP regulatory chain of TGF-beta (PubMed:22278742). Controls activation of TGF-beta-1 (TGFB1) on the surface of activated regulatory T-cells (Tregs) (PubMed:19750484, PubMed:19651619). Required for epithelial fusion during palate development by regulating activation of TGF-beta-3 (TGFB3) (By similarity).
Aliases: D11S833E antibody, GARP antibody, Garpin antibody, Glycoprotein A repetitions predominant antibody, Leucine rich repeat containing 32 antibody, Leucine-rich repeat-containing protein 32 antibody, LRC32_HUMAN antibody, LRRC32 antibody
- UniProt
- Q14392
- Pathways
- Activated T Cell Proliferation
-
